ARCHIVES

FDA Grants Orphan Designation To Photofrin for Mesothelioma

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill

May 9, 2014

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

ASCO Guideline On Breast Cancer Risk Reduction Updated

May 29, 2009